Global Healthcare Contract Manufacturing Market Research Report: Information by Type (Sterile and Non-Sterile), Service Type (Pharmaceutical Contract Manufacturing and Medical Device Contract Manufacturing), Industry (Pharmaceutical Industry, Medical Device Industry and Biopharmaceutical Industry) and Region (Americas, Europe, Asia-Pacific and Middle East & Africa) - Forecast till 2023
Market Scope
The global healthcare CMO market had touched the valuation of USD 129.91 billion in 2016, estimates Market Research Future (MRFR). It is projected to attain a CAGR of 9.86% during the forecast period (2017–2023), Growth Drivers and Top Restraints
Growth Factors and Key Challenges
The data analysts opine that the worldwide healthcare contract manufacturing market is expanding at a moderate but healthy rate. The chief factors backing the market growth include competition among companies with respect to the production and trade that favor CMO and the patent protection expiration of significant medical devices as well as drugs. Also, with both the contract manufacturers and clients reaping benefits and the agile form of manufacturing boosts market growth significantly.
Read More @ https://www.marketresearchfuture.com/sample_request/5637
Developing regions like Asia Pacific, Latin America and Middle East and Africa are experiencing potent growth of the biotechnology and pharmaceutical sectors. Several government bodies within these regions lend strong support in the form of numerous programs, conferences, initiatives as well as funding. The rapidly expanding pharmaceutical and biotechnology sectors lead to rise in demographic and economic growth along with surge in healthcare expenditures. On top of this, enhancement in the public-private healthcare funding has led to market growth in recent years. Therefore, developing areas across the globe are presumed to offer numerous growth opportunities to the healthcare CMO market in the following years.
The healthcare contract manufacturing market’s growth has been striking in the last few years owing to the numerous advantages offered by several international contract manufacturing companies. These companies offer a host of services to the pharmaceutical, medical device and biopharmaceutical companies. The pharmaceutical and biopharmaceutical companies enjoy numerous services by the CMO, whether it is the production of small amounts of materials for research and development (R&D) activities or huge funding for clinical study and commercialization.
Market Segmentation
The worldwide healthcare contract manufacturing market has been segmented on the basis of type, service type, and industry.
The type-wise segments are sterile and non-sterile. Non-sterile is believed to have the fastest growth rate of 10.0% from 2017 to 2023.
Depending on the service type, the market includes pharmaceutical contract manufacturing services, medical device contract manufacturing services.
The industries mentioned in the report are pharmaceutical, medical device, and biopharmaceutical.
Regional Analysis
Europe, Middle East and Africa, Asia Pacific and the Americas are the key markets for healthcare contract manufacturing.
The Americas has been identified as the leading healthcare contract manufacturing market, backed by high investment in healthcare and the presence of strong economy. The rising focus of research institutions on advancement of technology also benefits the regional market. Data experts note the rising focus of the contract manufacturers on the upgradation of their factories as well as manufacturing capabilities. As a result of cost-efficient models and advanced manufacturing units, the healthcare contract manufacturing market in the region is projected to expand considerably in the near future.
Europe is the second-most profitable market for healthcare contract manufacturing owing to the growing support from the governments and the high spending on healthcare. The Organization for Economic Co-operation and Development (OECD) reports that in 2014, the healthcare expenditure in Germany was around EUR 321 billion whereas France had the second highest healthcare expenditure of EUR 237 billion that year.
Growing at the fastest rate, Asia Pacific seems to possess lot of potential due to the high number of developing nations like India and China. These emerging economies are stimulating the growth of the healthcare contract manufacturing market, with the presence of highly developed healthcare infrastructure and the consistently advancing healthcare technology.
Middle East & Africa, with the least market share, lags behind due to less availability of medical facilities and poor development of the healthcare sector. But, countries like Kuwait and Qatar are striving to develop their medical facilities, which will have a positive impact on the overall regional market in the subsequent years.
Key Vendors
The key vendors identified by MRFR include Lonza Ag, Catalant, Patheon, Mylan, Teva Pharmaceutical Industries, Benchmark Electronics, Vetter Pharma International, AbbVie, Boehringer Ingelheim, Aesica Pharmaceuticals, Grifols International, S.A, Hamilton Company, Sanmina Corporation, Flex Ltd, Forefront Medical Technologies, Evonik Industries to name a few.
Latest Developments
April 2019
Catalent will be acquiring Paragon Bio-services, a contract manufacturing organization with focus on viral vectors that are used in gene therapies, for the cost of USD 1.2 billion.
Read More @ https://www.marketresearchfuture.com/reports/healthcare-contract-manufacturing-market-5637
NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact:
Akash Anand
Market Research Future
+1 646 845 9312
Email: [email protected]
The market relies heavily on the outsourcing of the manufacturing process of drugs to contract manufacturers.
From drug development to drug manufacturing, a comprehensive platform this healthcare contract manufacturing sector provides.
The from drug development to drug manufacturing market is expecting a growth by 9.86% during the forecast period (2017-2023), claims Market Research Future (MRFR).
Among the factors, patent expiration of several drugs can be deemed as one of the chief influencers that can foster the market growth during the forecast period.
Emerging economies are demanding for greater percolation as the population boom in those countries have created scope for substantial market expansion.
Drug manufacturers are also looking for significant contribution from these companies as number of drugs in the pipeline is getting piled up.
Healthcare Contract Manufacturing Market ScopeThe global healthcare contract manufacturing market had touched the valuation of USD 129.91 billion in 2016, estimates Market Research Future (MRFR).
The chief factors backing the market growth include competition among companies with respect to the production and trade that favor CMO and the patent protection expiration of significant medical devices as well as drugs.
Also, with both the contract manufacturers and clients reaping benefits and the agile form of manufacturing boosts market growth significantly.Developing regions like Asia Pacific, Latin America and Middle East and Africa are experiencing potent growth of the biotechnology and pharmaceutical sectors.
The pharmaceutical and biopharmaceutical companies enjoy numerous services by the CMO, whether it is the production of small amounts of materials for research and development (R) activities or huge funding for clinical study and commercialization.Healthcare Contract Manufacturing Market SegmentationThe worldwide healthcare contract manufacturing market has been segmented on the basis of type, service type, and industry.The type-wise segments are sterile and non-sterile.
Non-sterile is believed to have the fastest growth rate of 10.0% from 2017 to 2023.Depending on the service type, the market includes pharmaceutical contract manufacturing services, medical device contract manufacturing services.The industries mentioned in the report are pharmaceutical, medical device, and biopharmaceutical.Healthcare Contract Manufacturing Market Regional AnalysisEurope, Middle East and Africa, Asia Pacific and the Americas are the key markets for healthcare contract manufacturing.The Americas has been identified as the leading healthcare contract manufacturing market, backed by high investment in healthcare and the presence of strong economy.
The rising focus of research institutions on advancement of technology also benefits the regional market.
The global healthcare contract manufacturing market size was valued at USD 177.9 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 7.7% from 2021 to 2028.
An increase in offshoring to emerging countries and the changing regulatory landscape are the prominent trends currently present in the market.
The U.S. FDA has observed that over 60% of FDA-regulated products imported from China are medical devices, making the U.S. medical device industry highly dependent on China’s supply chain.
The presence of end-to-end service providers that are engaged in providing value-added services for an integrated or risk-sharing business model is expected to boost the market growth.
It allows manufacturers to be more dynamic and cost effective in their manufacturing process.
Product Segment Analysis: Medical Device PharmaceuticalAccess Press Release @ https://www.grandviewresearch.com/press-release/global-contract-manufacturing-market Regional Segment Analysis:North AmericaEuropeAsia PacificLatin AmericaMiddle East & Africa Companies are adopting strategies, such as mergers and acquisitions and expansion, to sustain in the highly competitive environment and maintain profitability.
